ConductScience.org, home

Gene · 3913

NIH grants2,633

NIH grants whose papers are about the gene, through NIH's grant-paper links.

261 to 280 of 2,633

Download this page as JSON
GrantTitleLAMB2 papersNewest fiscal year
R01DK098672Regulation of Mitochondrial Function by Orphan Protein Phosphatases12025
R01DK099528Gradient biomaterials to investigate niche regulation of hematopoiesis12025
R01DK105124Genetics of IgA nephropathy by integrative network-based association studies12025
R01DK106104Regulation of Metabolism by FGF2112025
R01DK111599Biomechanical Determinants of Hematopoietic Stem Cell Potential12025
R01DK120921Photoresponsive materials to study matricellular signaling dynamics during crypt formation and fission12025
R01DK124804Genetic and extrinsic mechanisms governing early enteric nervous system development12025
R01DK128282Biochemical and cellular mechanisms linking actin mutations to visceral myopathy12025
R01DK128660Innovative Approaches to Treating Alport Syndrome12025
R01EB009745Discrete Frequency Infrared Spectroscopic Imaging for Breast Histopathology12025
R01ES026033Organic-metal mixtures and neurodevelopment12025
R01ES027051Revealing environmental chemical exposome in a diverse prenatal population and relationships to maternal and perinatal health (REVEAL)12025
R01ES030722Genetic and epigenetic mechanisms of infertility caused by endocrine disrupting chemicals12025
R01ES033630Modeling the interaction of physiological and environmental stressors on common variants to psychiatric traits12025
R01EY011600Biochemistry and Pharmacology of the Macular Carotenoids12025
R01EY013124Immunopathogenesis of Adenovirus Keratitis12025
R01EY015279The Influence of Capsule Composition on Lens Biology12025
R01EY019887Genetically testing mechanisms of ocular development and disease12025
R01EY021558Novel Mechanisms in Adenoviral Ocular Pathogenesis12025
R01EY021797Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3913/grants?page=14